Avidity
Di Andrews is a seasoned professional in corporate communications and administrative support with extensive experience in the biotechnology and consulting sectors. Currently serving as the Manager of Corporate Communications and Investor Relations at Avidity Biosciences, Inc. since August 2020, Di has previously held notable positions including Office Manager and Executive Administrator to the CEO at Akcea Therapeutics, where responsibilities also included supporting the President. Other roles include Executive Administrator to the CBO & SVP at Ionis Pharmaceuticals and various administrative positions at Bates White Economic Consulting, Newgen Results, and the American Council on Exercise. Throughout these roles, Di has demonstrated expertise in managing office operations, providing executive support, and maintaining professional relationships across various levels of leadership.
This person is not in the org chart
This person is not in any teams
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.